Biotechnology Assets, S.A. (BST:041)

Market Cap	13.98M -34.9%
Revenue (ttm)	3.05M -9.5%
Net Income	-2.08M
EPS	n/a
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.1910
Previous Close	0.1910
Day's Range	0.1860 - 0.1940
52-Week Range	0.1130 - 0.5240
Beta	n/a
RSI	50.90
Earnings Date	Apr 2, 2026

About Biotechnology Assets

Biotechnology Assets, S.A. develops and markets biotechnological assets for applications in the biopharmaceutical, agrochemical, cosmetic, veterinary, and chemical industries in Spain and internationally. It offers SPLITTERA, a protein engineering tool that allows the conjugation of proteins through the formation of new peptide bonds; universal switchable split-chimeric antigen receptor (CAR); VACC-ZERA technology, a tool to generate recombinant proteins in microparticles suited for therapeutic and prophylactic adjuvant free vaccines administer...

• Industry: Pharmaceutical Preparations
• CEO: Jaime Feced Rubio
• Employees: 30
• Stock Exchange: Stuttgart Stock Exchange
• Ticker Symbol: 041